The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pizzuti Dana since 2023.
This trader's CIK number is 1948238.
At the time of last reporting, Pizzuti Dana was the Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX).
Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CRNX | 0 | $0 | 64,007 | $2,326,303 | 57,500 | $978,050 |
| 2024 | CRNX | 0 | $0 | 72,589 | $3,240,939 | 71,875 | $1,213,965 |
| 2023 | CRNX | 0 | $0 | 17,795 | $463,907 | 9,583 | $161,856 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | CRNX | Option Ex | 5,000 | 16.89 | 84,450 |
| 2025-09-02 | CRNX | Sale | 5,000 | 32.10 | 160,500 |
| 2025-08-22 | CRNX | Option Ex | 30,000 | 16.89 | 506,700 |
| 2025-08-22 | CRNX | Sale | 30,000 | 30.43 | 912,900 |
| 2025-08-20 | CRNX | Sale | 6,492 | 29.18 | 189,436 |
| 2025-03-19 | CRNX | Sale | 2,515 | 34.50 | 86,767 |
| 2025-02-03 | CRNX | Option Ex | 5,000 | 16.89 | 84,450 |
| 2025-02-03 | CRNX | Sale | 5,000 | 39.07 | 195,350 |
| 2025-01-07 | CRNX | Option Ex | 2,500 | 19.64 | 49,100 |
| 2025-01-03 | CRNX | Option Ex | 15,000 | 16.89 | 253,350 |
| 2025-01-03 | CRNX | Sale | 15,000 | 52.09 | 781,350 |
| 2024-10-03 | CRNX | Option Ex | 14,375 | 16.89 | 242,793 |
| 2024-10-03 | CRNX | Sale | 14,375 | 54.63 | 785,306 |
| 2024-07-03 | CRNX | Option Ex | 14,375 | 16.89 | 242,793 |
| 2024-07-03 | CRNX | Sale | 14,375 | 44.87 | 645,006 |
| 2024-04-15 | CRNX | Option Ex | 14,375 | 16.89 | 242,793 |
| 2024-04-15 | CRNX | Sale | 14,375 | 44.47 | 639,256 |
| 2024-03-20 | CRNX | Sale | 15,089 | 44.29 | 668,246 |
| 2024-03-20 | CRNX | Option Ex | 14,375 | 16.89 | 242,793 |
| 2024-01-03 | CRNX | Sale | 14,375 | 35.00 | 503,125 |
| 2024-01-03 | CRNX | Option Ex | 14,375 | 16.89 | 242,793 |
| 2023-12-21 | CRNX | Option Ex | 9,583 | 16.89 | 161,856 |
| 2023-12-21 | CRNX | Sale | 9,583 | 34.57 | 331,284 |
| 2023-04-05 | CRNX | Sale | 8,212 | 16.15 | 132,623 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pizzuti Dana (Chief Med and Dev Officer of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.